Last reviewed · How we verify
divalproex or olanzapine
At a glance
| Generic name | divalproex or olanzapine |
|---|---|
| Sponsor | Mayo Clinic |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders (NA)
- Efficacy of Hydroxyzine for Patients With Panic Disorder (PHASE4)
- Pharmacovigilance in Gerontopsychiatric Patients (PHASE3)
- Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode (PHASE3)
- An Evaluation of Divalproex vs. Olanzapine for Alcohol Abuse Relapse Prevention in Patients With Bipolar Disorder (PHASE4)
- Comparative Efficacy and Acceptability of Antimanic Drugs in Acute Mania (PHASE4)
- A Comparison of Two Standard Therapies in the Management of Dementia With Agitation (PHASE4)
- Effectiveness of Lithium and Valproate in Treating High-Risk Bipolar Disorder (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |